Design and synthesis of novel 2-aminochromone and 2- aminoquinolinone-containing 1,2,3 triazol, Isoxazole, 1,2,4-oxadiazol, and carboxamides: Biological evaluation for anti-HIV and anti-cancer activities
Implementing Organization
Osmania University
Principal Investigator
Dr. T Gangadhar thalari
Osmania University
About
The study aims to design and synthesize novel 2-aminochromone and 2-aminoquinolinone-containing 1,2,3 triazol, Isoxazole, 1,2,4-oxadiazol, and carboxamides with anti-HIV and anti-cancer activities. These five-membered heterocyclic moieties are crucial in medicinal chemistry and are essential structural components in bioactive analogues. The researchers will use a computational tool to design novel heterocyclic analogues of 2-amino chromones and 2-amino quinolinones. The compounds will be evaluated against various protein kinases and their molecular docking study will be performed using the Autodock Vina program. The results will be compiled and documented, and a manuscript or patent will be written accordingly. The study aims to provide valuable insights into the interactions and binding of these compounds.
Source
Source
Anusandhan National Research Foundation/science and Engineering Research Board (sERB), DsT 2023-24
Science and Engineering Research Board (SERB), New Delhi
Anusandhan National Research Foundation (ANRF)
Quick Information
Area of Research
Chemical Sciences
Start Year
2023
End Year
2026
Sanction Amount
₹ 28.30 L
Status
Ongoing
Contact
ganguly.chem@gmail.com
Output
No. of Research Paper
00
Technologies (If Any)
00
No. of PhD Produced
00
No. of Patents
Filed :00
Grant :00
Disclaimer:
Information available on this portal is sourced from various organizations and is provided for informational purposes only. Users are advised to verify details from the respective official sources.
Please enter your details
Please provide your name and email to continue. Your details are saved in this browser for future use.
Latest Updates
Loading…
⚠️
You are leaving this website
You are about to be redirected to an external website that is not operated by
India Science, Technology & Innovation (ISTI) Portal.